The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
Open accessAbstract
Immediate-early genes, such as c-fos, are responsive to dopaminergic stimulation in the brain and can have prolonged effects on the transcription of other genes. Thus, they may mediate some of the long-term consequences of altered dopaminergic transmission on striatal neurons, such as the supersensitivity to dopamine and its agonists that occurs in response to dopamine denervation. The two dopamine receptor families, D1 and D2, interact synergistically under normal conditions but independently after treatments that induce pronounced supersensitivity to dopamine agonists. Using immunocytochemical methods in rats treated with directly acting selective dopamine agonists, we have determined that dopamine-mediated expression of Fos and Fos-like antigens in the striatum normally requires concomitant stimulation of D1 and D2 receptors. Separate administration of a high dose of a selective D1 (SKF 38393; 20 mg/kg) or D2 (quinpirole; 3 mg/kg) agonist induced Fos-like immunoreactivity in few neurons, whereas combined administration of the D1 and D2 agonists produced patches of intensely stained immunoreactive nuclei in the caudate-putamen. Repeated administration of reserpine (1 mg/kg per day for 5 days), which causes supersensitivity to dopamine agonists and a breakdown in D1/D2 synergism behaviorally, also causes a change in control of c-fos, such that independent stimulation of D1 receptors by SKF 38393 (20 mg/kg) elicited pronounced Fos-like immunoreactivity in the striatum; combined treatment with SKF 38393 (20 mg/kg) and quinpirole (3 mg/kg) in reserpine-treated rats elicited Fos-like expression in no more neurons than did D1 agonism alone. These data demonstrate that dopamine-mediated Fos expression in the striatum is indicative of the state of D1/D2 synergism and receptor supersensitivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Under normal conditions, a synergistic balance of D1R- and D2R-like activation exists in striatal regions (Walters et al 1987; LaHoste et al 1993; Gerfen et al 1995; Wise et al 1996; Hu and White 1997).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as LaHoste et al 1993
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131
Morgan, J., & Curran, T. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002225 · Cited by 2,689
The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia
Gerfen, C. R. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.001441 · Cited by 1,004
Molecular biology of dopamine receptors
Sibley, D. R., & Monsma, F. J. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90025-2 · Cited by 993
Graybiel, A. M., Moratalla, R., & Robertson, H. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6912 · Cited by 957
Regulation of Proenkephalin by Fos and Jun
Sonnenberg, J. L., Rauscher, F. J., Morgan, J. I., & Curran, T. (1989) · Science · doi:10.1126/science.2512642 · Cited by 532
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors.
Young, S., Porrino, L. J., & Iadarola, M. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1291 · Cited by 497
Robertson, G. S., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90054-6 · Cited by 474
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–182 of 182
Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation
Wang, Y., & Zhou, F.-M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00935 · Cited by 21
Wirtshafter, D., Schardt, G., & Asin, K. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00795-6 · Cited by 21
Amphetamine induces Fos-like immunoreactivity in the striatum of primates
Asin, K. E., Wirtshafter, D., & Nikkel, A. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00140-0 · Cited by 19
Duke, M. A., Meier, T. L., Bolaños, C. A., Crawford, C. A., & McDougall, S. A. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.5.1114 · Cited by 18
Dopaminergic regulation of AP-1 transcription factor DNA binding activity in rat striatum
Huang, K.-X., & Walters, J. R. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00229-1 · Cited by 18
D1/D2 Dopamine Receptor Interactions in Basal Ganglia Functions
Marshall, J. F., Ruskin, D. N., & LaHoste, G. J. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2635-0_7 · Cited by 18
Self-citationRowland, N. E., Roth, J. D., McMullen, M. R., Patel, A., & Cespedes, A. T. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.2.r390 · Cited by 17
Horner, K. A., Noble, E. S., & Gilbert, Y. E. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.019 · Cited by 16
The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats
Wirtshafter, D., & Osborn, C. V. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.003 · Cited by 16
Wirtshafter, D., & Asin, K. E. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03315-1 · Cited by 16
Jorge-Mora, T., Agustiño, M. J. M., Rodríguez-González, J. A., Jorge-Barreiro, F. J., Ares‐Pena, F., & López-Martín, M. E. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0557-4 · Cited by 15
Behavioral synergism between D1 and D2 dopamine receptors in mice does not depend on gap junctions
Nolan, E., Harrison, L. M., LaHoste, G. J., & Ruskin, D. N. (2007) · Synapse · doi:10.1002/syn.20371 · Cited by 15
Self-citationFunctional interaction between dopamine receptor subtypes for the regulation of c-fos expression
Cho, D.-I., Quan, W., Oak, M., Choi, H. J., Lee, K. Y., & Kim, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.066 · Cited by 15
Daya, R. P., Tan, M. L., Sookram, C. D., Skoblenick, K. J., & Mishra, R. K. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.014 · Cited by 14
Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists
Cook, D. F., & Wirtshafter, D. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00184-8 · Cited by 14
Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells
Hwang, O., Baker, H. A., Gross, S. S., & JOH, T. H. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199802)28:2 · Cited by 62
David, H. (2009) · Current Neuropharmacology · doi:10.2174/157015909788848893 · Cited by 12
Wirtshafter, D. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01269-6 · Cited by 12
Wirtshafter, D., & Krebs, J. C. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01353-4 · Cited by 11
Candidate gene study reveals DRD1 and DRD2 as putative interacting risk factors for youth depression
Corrales, E., Navarro, A., Cuenca, P., & Campos, D. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.032 · Cited by 11
Stereotyped behavior or punding in Parkinson's disease
Miwa, H. (2007) · Journal of Neurology · doi:10.1007/s00415-007-5010-x · Cited by 11
Anxiolytic homophthalazines increase Fos-like immunoreactivity in selected brain areas of the rat
Palkovits, M., Baffi, J., Berzsenyi, P., & Horváth, E. J. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01008-x · Cited by 11
Wacan, J. J., Reichel, C. M., Farley, C. M., & McDougall, S. A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0263-5 · Cited by 11
Login, I. S., Borland, K., & Harrison, M. B. (1995) · Brain Research · doi:10.1016/0006-8993(95)00295-2 · Cited by 11
Psychostimulant-Induced Gene Regulation in Corticostriatal Circuits
Steiner, H. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00029-9 · Cited by 11
Ott, M. C., Costain, W. J., Mishra, R. K., & Johnson, R. L. (2000) · Peptides · doi:10.1016/s0196-9781(99)00194-1 · Cited by 10
Griffiths, M., Mitchell, I., & Cooper, A. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01120-8 · Cited by 10
Rouillon, C., Degoulet, M., Chevallier, K., Abraini, J. H., & David, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.025 · Cited by 10
Rouillon, C., Abraini, J. H., & David, H. (2007) · Hippocampus · doi:10.1002/hipo.20337 · Cited by 10
Psychostimulant-Induced Gene Regulation in Striatal Circuits
Steiner, H. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00031-3 · Cited by 9
Early Changes in Neuropeptide mRNA Expression in the Striatum Following Reserpine Treatment
Harrison, M. B., Kumar, S., Hubbard, C., & Trugman, J. M. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7555 · Cited by 10
A D1 dopamine agonist stimulates acetylcholine release from dissociated striatal cholinergic neurons
Login, I. S., & Harrison, M. B. (1996) · Brain Research · doi:10.1016/0006-8993(96)00364-2 · Cited by 10
Attenuation of cocaine-induced genomic and functional responses in prenatal cocaine-exposed rabbits
Tilakaratne, N., Cai, G., & Friedman, E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00534-2 · Cited by 10
Wardas, J. (2003) · PubMed · Cited by 10
Exploration of sex differences in Rhes effects in dopamine mediated behaviors
Garzola, G. C. Q., & Spano, D. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s25888 · Cited by 9
Kashihara, K., Manabe, Y., Shiro, Y., Warita, H., & Abe, K. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)00167-x · Cited by 9
Rushlow, W. J., Rajakumar, B. S. J., Flumerfelt, B. A., Naus, C. C. G., & Rajakumar, N. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00104-4 · Cited by 9
Sandstrom, M. I., Sarter, M. F., & Bruno, J. P. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00103-4 · Cited by 9
Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity
Marı́n, C., & TOLOSA, E. S. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00097-x · Cited by 9
Quinpirole attenuates the striatal Fos expression induced by escape behavior
Struthers, W. M., & Wirtshafter, D. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01378-4 · Cited by 9
Fluorescent Tools for the Imaging of Dopamine D2‐Like Receptors**
Nagl, M., Mönnich, D., Rosier, N., Schihada, H., Sirbu, A., Konar, N., Reyes‐Resina, I., Navarro, G., Franco, R., Kolb, P., et al. (2023) · ChemBioChem · doi:10.1002/cbic.202300659 · Cited by 8
D1/D2 receptor synergism on CREB DNA-binding activities in the caudate-putamen of rat
Kashihara, K., Ishihara, T., Akiyama, K., & Abe, K. (1999) · Neurological Research · doi:10.1080/01616412.1999.11741014 · Cited by 8
Presynaptic dopamine D4 receptor localization in the rat nucleus accumbens shell
Svingos, A. L., Periasamy, S., & Pickel, V. M. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3 · Cited by 58
Self-citationPalacios, G., Muro, A., & Marín, A. P. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00975-4 · Cited by 7
Paracrine Regulation of Renal Function by Dopamine
Holtbäck, U., & Aperia, A. C. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50021-8 · Cited by 6
Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors
DallʼOlio, R., GAGGI, R., Voltattorni, M., Tanda, O., & Gandolfi, O. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200212000-00004 · Cited by 6
Enhanced AP-1 binding in brain induced by D1 and D2 agonists in methamphetamine-sensitized rats
Ishihara, T., Akiyama, K., & Kashihara, K. (1998) · Neuroreport · doi:10.1097/00001756-199812010-00027 · Cited by 6
Kiessling, C. Y., Lanza, K., Feinberg, E. N., & Bishop, C. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108138 · Cited by 5
Farley, C. M., Baella, S. A., Wacan, J. J., Crawford, C. A., & McDougall, S. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.068 · Cited by 5
Effect of apomorphine on striatal synaptotagmin 7 mRNA levels in reserpinized rats
Pal, R., Živin, M., Milutinović, A., Jernej, B., & Glavan, G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.07.033 · Cited by 5
Wirtshafter, D., & Sheppard, A. C. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.09.002 · Cited by 5
Sim, L. J., Selley, D. E., Tsai, K. P., & Morris, M. (1994) · Brain Research · doi:10.1016/0006-8993(94)90711-0 · Cited by 5
Dopaminergic Regulation of Immediate Early Gene Expression in the Basal Ganglia
Marshall, J. F., Ruskin, D. N., & LaHoste, G. J. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60839-x · Cited by 4
Self-citationNeurotransmitter Regulation of Basal Ganglia Gene Expression
Keefe, K. A., & Horner, K. A. (2010) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-374767-9.00027-5 · Cited by 3
Steiner, H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72256-6_18 · Cited by 3
Guerra, M. J., Liste, I., Rozas, G., Tobio, J. P., & Labandeira-García, J. L. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)12445-9 · Cited by 3
Cook, D. F., & Wirtshafter, D. (2000) · Brain Research · doi:10.1016/s0006-8993(99)01993-9 · Cited by 3
Hug, F., Degen, T., Meurs, P., & Fischmann, T. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.809616 · Cited by 2
Zhang, J., Ding, D., Yang, S., Tao, Q.-F., Yang, Y., & Zhou, W. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153989 · Cited by 2
The acetylcholine release enhancer linopirdine induces Fos in neocortex of aged rats
Dent, G. W., Rule, B. L., Zhan, Y., & Grzanna, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00252-9 · Cited by 2
Narayanan, S., Dalia, A., Wallace, L. J., & Uretsky, N. J. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00030-0 · Cited by 1
Sensitivity to Dopamine D1/D2 Receptor Stimulation in Mice Lacking Connexin-32 or Connexin-36
Mckenna, J. T. (2004) · ScholarWorks @ The University of New Orleans (The University of New Orleans) · Cited by 1
D1 Dopamine Receptors, Schizophrenia, and Antipsychotic Medications
Kurumaji, A., & Okubo, Y. (2000) · Handbooks of pharmacology and toxicology · doi:10.1201/9781420041774.ch5 · Cited by 1
Fluorescent Tools for Imaging and Ligand Screening of Dopamine D 2 -Like ReceptorsPreprint
Nagl, M., Mönnich, D., Rosier, N., Schihada, H., Sirbu, A., Konar, N., Reyes‐Resina, I., Navarro, G., Franco, R., Kolb, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.25.559398 · Cited by 1
Morrissey, J. J., Raney, S. R., Heasley, E., Rathinavelu, P., Dauphinée, M. J., & Fallon, J. H. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4867-6_25 · Cited by 1
Molekulare Grundlagen der Interaktion zwischen Dopamin-(D1-/D2-)Rezeptoren
Niznik, H. B., Sunahara, R. K., Pristupa, Z. B., & Jarvie, K. R. (1995) · Springer eBooks · doi:10.1007/978-3-642-79738-5_1 · Cited by 1
The Role of Connexin36 in Dopamine D1/D2 Synergism and its Breakdown in Transgenic Mice
Nolan, E. (2006) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
Towards a Novel Treatment of Huntington´s Disease
Esmaeilzadeh, M. (2011) · Figshare
Huggins, K. N. (2009) · Digital Commons - East Tennessee State University (East Tennessee State University)
Kleinman, A., Tieppo, C. A., FLOREZ, G., Felício, L. F., & Nasello, A. G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.014
Données actuelles sur la physiopathologie du syndrome de Gilles de la Tourette
Derost, P., Galland, F., Legrand, G., Mermillod, M., Auxiette, C., Chambres, P., Jalenques, I., & Durif, F. (2008) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2008.04.002
Interactions of the Striatal Gene Rhes with the Dopaminergic System in Rodents
Garzola, G. C. Q. (2007) · ScholarWorks @ The University of New Orleans (The University of New Orleans)
Parkinson’s Disease, the Dopamine System and Immediate Early Genes
Zhang, X., & Svenningsson, P. (2006) · Springer eBooks · doi:10.1007/978-0-387-33604-6_14
Banasikowski, T. J. (2012) · QSpace (Queen's University Library)
The preproglucagon derived peptides and energy homeostasis
Parker, J. (2013) · doi:10.25560/10956
Chopra, R. (2020) · Deep Blue (University of Michigan)
Gerfen, C. R. (2005) · Springer eBooks · doi:10.1007/0-387-28066-9_25
In Vivo Laboratory Experiments Related to Cellular Telephone Communications
Swicord, M. L., & Morrissey, J. J. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4867-6_24
Kaste, K. (2009) · Työväentutkimus Vuosikirja
In Vitro Laboratory Experiments Related to Cellular Telephone Communication
Veyret, B., & Morrissey, J. J. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4867-6_23
Metadata
- Authors
- LaHoste, G. J., Yu, J., & Marshall, J. F.
- Affiliations
- University of California, Irvine (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1993-08-15
- Volume
- 90
- Issue
- 16
- Pages
- 7451-7455
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC47159
- OpenAlex
- W2047619967
- Cited by
- 182
- References
- 35
- Citations by year
- 2023: 2 · 2022: 3 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p50mh044188-05, 1r01ns028846-01)
- U.S. Public Health Service
- National Institute of Mental Health (MH44188)
- National Institute of Neurological Disorders and Stroke (NS22698, NS 28846, R01NS022698)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- c-fos, Fos-like immunoreactivity, dopamine D1 receptor, dopamine D2 receptor, receptor supersensitivity, striatum, caudate-putamen, dopamine agonists, reserpine, dopaminergic denervation, immediate early genes, striatal neurons
- MeSH terms
- Animals, Corpus Striatum, Drug Synergism, Ergolines, Immunohistochemistry, Male, Reference Values, Reserpine, Dopamine Agents, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Proto-Oncogene Proteins c-fos, Genes, fos, Rats, Sprague-Dawley, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review